MYDA Advisors’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,000
Closed -$326K 171
2024
Q1
$326K Buy
+1,000
New +$246K 0.09% 93
2023
Q4
Sell
-5,000
Closed -$996K 133
2023
Q3
$996K Buy
+5,000
New +$1.18M 0.32% 54
2022
Q3
Sell
-2,000
Closed -$382K 218
2022
Q2
$382K Sell
2,000
-2,000
-50% -$353K 0.11% 130
2022
Q1
$829K Sell
4,000
-1,000
-20% -$165K 0.33% 93
2021
Q4
$892K Sell
5,000
-2,500
-33% -$493K 0.24% 119
2021
Q3
$1.54M Sell
7,500
-500
-6% -$98.2K 0.43% 59
2021
Q2
$1.52M Sell
8,000
-2,000
-20% -$327K 0.38% 83
2021
Q1
$1.3M Hold
10,000
0.36% 88
2020
Q4
$1.04M Buy
+10,000
New +$866K 0.31% 81
2019
Q4
Sell
-13,000
Closed -$389K 166
2019
Q3
$389K Buy
+13,000
New +$552K 0.18% 71

Other funds holding SWAV

MYDA Advisors's SWAV Position: Q2 2024 in Review

MYDA Advisors sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 1,000 shares — an estimated $326K sold.

MYDA Advisors first reported a position in SWAV in Q3 2019 and held it in 10 quarters. The position peaked at $1.54M in Q3 2021. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • MYDA Advisors reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • MYDA Advisors sold 1,000 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $326K.
  • MYDA Advisors first reported a position in Shockwave Medical, Inc. Common Stock in Q3 2019 and held it in 10 quarters.
  • MYDA Advisors's Shockwave Medical, Inc. Common Stock position peaked at $1.54M in Q3 2021.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on MYDA Advisors's 13F filing for Q2 2024, filed 13 Aug 2024.